Literature DB >> 17036336

Whole genome microarray analysis of gene expression in an imprinting center deletion mouse model of Prader-Willi syndrome.

Douglas C Bittel1, Nataliya Kibiryeva, Steven G McNulty, Daniel J Driscoll, Merlin G Butler, Robert A White.   

Abstract

Prader-Willi syndrome (PWS) is caused by loss of paternally expressed genes in the 15q11-q13 region. To further characterize alterations in gene expression in this classical obesity syndrome we used whole genome microarrays to study a PWS mouse model resulting from a paternally derived imprinting center (IC) deletion (PWS IC deletion). These mice die generally within 2-3 days of life (reflective of failure to thrive in infants with PWS) and therefore, the analysis was performed on RNA extracted from the whole brain of PWS IC deletion mice and normal littermates at less than 24 hr after birth. Of more than 45,000 probes examined, 26,471 (59%) were detected for further analysis, and 69 had a significant change in expression of at least 1.5-fold and a false discovery rate (FDR) of 5%. Eight of the genes with differential expression were imprinted and from the PWS critical region (PWSCR). The three genes with the highest expression in the PWS IC mice were pro-opiomelanocortin (Pomc) and two transcripts of unknown function. Pomc knockout mice have been shown to develop obesity. Therefore, elevated Pomc RNA in PWS IC deletion neonatal mice may be an important genetic factor in the survival of these mice as it may affect eating behavior. Interestingly, Mc5r, a melanocortin receptor known to directly respond to Pomc expression changes, was upregulated as well. Mc5r is known to be involved with thermoregulation which is reportedly abnormal in PWS infants. These observations support a role for Pomc and the network of genes involved in regulating energy homeostasis in the early clinical findings of failure to thrive observed in PWS. Other notable patterns include three previously unstudied transcripts that are expressed only from the paternal allele under regulatory control of the IC and include AK013560, BB3144814, and BB182944 (whose genes are located in the mouse PWSCR on chromosome 7B). As expected, all the known paternally expressed genes from the PWSCR had detection signals below the threshold in the PWS IC deletion mice but were clearly detectable in control littermates. Several of the genes in this study were further examined by quantitative reverse transcription-PCR (RT-PCR) to confirm their expression status. Further analysis of gene expression in these mice may lead to novel pathways affected in PWS. These results, along with other recent reports, suggest that the cumulative effect of modest changes in expression of many genes, especially genes involved in energy metabolism, contribute to the failure to thrive of infants with PWS. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17036336      PMCID: PMC5453790          DOI: 10.1002/ajmg.a.31504

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  36 in total

1.  Incriminating gene suspects, Prader-Willi style.

Authors:  R D Nicholls
Journal:  Nat Genet       Date:  1999-10       Impact factor: 38.330

Review 2.  Genome organization, function, and imprinting in Prader-Willi and Angelman syndromes.

Authors:  R D Nicholls; J L Knepper
Journal:  Annu Rev Genomics Hum Genet       Date:  2001       Impact factor: 8.929

3.  The IC-SNURF-SNRPN transcript serves as a host for multiple small nucleolar RNA species and as an antisense RNA for UBE3A.

Authors:  M Runte; A Hüttenhofer; S Gross; M Kiefmann; B Horsthemke; K Buiting
Journal:  Hum Mol Genet       Date:  2001-11-01       Impact factor: 6.150

4.  Microarray analysis of gene/transcript expression in Angelman syndrome: deletion versus UPD.

Authors:  Douglas C Bittel; Nataliya Kibiryeva; Zohreh Talebizadeh; Daniel J Driscoll; Merlin G Butler
Journal:  Genomics       Date:  2005-01       Impact factor: 5.736

5.  Positional cloning of the Ttc7 gene required for normal iron homeostasis and mutated in hea and fsn anemia mice.

Authors:  Robert A White; Steven G McNulty; Ndona N Nsumu; Leigh A Boydston; Brandon P Brewer; Koji Shimizu
Journal:  Genomics       Date:  2005-03       Impact factor: 5.736

6.  Retrotransposed genes such as Frat3 in the mouse Chromosome 7C Prader-Willi syndrome region acquire the imprinted status of their insertion site.

Authors:  J H Chai; D P Locke; T Ohta; J M Greally; R D Nicholls
Journal:  Mamm Genome       Date:  2001-11       Impact factor: 2.957

7.  A nonimprinted Prader-Willi Syndrome (PWS)-region gene regulates a different chromosomal domain in trans but the imprinted pws loci do not alter genome-wide mRNA levels.

Authors:  Mihaela Stefan; Toni Portis; Richard Longnecker; Robert D Nicholls
Journal:  Genomics       Date:  2005-05       Impact factor: 5.736

8.  Expression and imprinting of MAGEL2 suggest a role in Prader-willi syndrome and the homologous murine imprinting phenotype.

Authors:  S Lee; S Kozlov; L Hernandez; S J Chamberlain; C I Brannan; C L Stewart; R Wevrick
Journal:  Hum Mol Genet       Date:  2000-07-22       Impact factor: 6.150

Review 9.  Prader-Willi syndrome: clinical genetics, cytogenetics and molecular biology.

Authors:  Douglas C Bittel; Merlin G Butler
Journal:  Expert Rev Mol Med       Date:  2005-07-25       Impact factor: 5.600

10.  A 9-year-old male with a duplication of chromosome 3p25.3p26.2: clinical report and gene expression analysis.

Authors:  Douglas C Bittel; Nataliya Kibiryeva; Majed Dasouki; Joan H M Knoll; Merlin G Butler
Journal:  Am J Med Genet A       Date:  2006-03-15       Impact factor: 2.802

View more
  11 in total

1.  Influence of the Prader-Willi syndrome imprinting center on the DNA methylation landscape in the mouse brain.

Authors:  Jason O Brant; Alberto Riva; James L Resnick; Thomas P Yang
Journal:  Epigenetics       Date:  2014-11       Impact factor: 4.528

2.  EVALUATION OF PLASMA SUBSTANCE P AND BETA-ENDORPHIN LEVELS IN CHILDREN WITH PRADER-WILLI SYNDROME.

Authors:  M G Butler; T A Nelson; D J Driscoll; A M Manzardo
Journal:  J Rare Disord       Date:  2015-09

Review 3.  Oxytocin and vasopressin systems in genetic syndromes and neurodevelopmental disorders.

Authors:  S M Francis; A Sagar; T Levin-Decanini; W Liu; C S Carter; S Jacob
Journal:  Brain Res       Date:  2014-01-22       Impact factor: 3.252

4.  Neonatal maternal deprivation response and developmental changes in gene expression revealed by hypothalamic gene expression profiling in mice.

Authors:  Feng Ding; Hong Hua Li; Jun Li; Richard M Myers; Uta Francke
Journal:  PLoS One       Date:  2010-02-24       Impact factor: 3.240

5.  Analysis of the Prader-Willi syndrome chromosome region using quantitative microsphere hybridization (QMH) array.

Authors:  H L Newkirk; D C Bittel; M G Butler
Journal:  Am J Med Genet A       Date:  2008-09-15       Impact factor: 2.802

6.  Recommendations for the investigation of animal models of Prader-Willi syndrome.

Authors:  James L Resnick; Robert D Nicholls; Rachel Wevrick
Journal:  Mamm Genome       Date:  2013-04-23       Impact factor: 2.957

7.  Genome-wide gene expression in a patient with 15q13.3 homozygous microdeletion syndrome.

Authors:  Jean-Baptiste Le Pichon; Shihui Yu; Nataliya Kibiryeva; William D Graf; Douglas C Bittel
Journal:  Eur J Hum Genet       Date:  2013-01-30       Impact factor: 4.246

8.  Gene expression in cardiac tissues from infants with idiopathic conotruncal defects.

Authors:  Douglas C Bittel; Merlin G Butler; Nataliya Kibiryeva; Jennifer A Marshall; Jie Chen; Gary K Lofland; James E O'Brien
Journal:  BMC Med Genomics       Date:  2011-01-05       Impact factor: 3.063

Review 9.  New Perspectives on Genomic Imprinting, an Essential and Multifaceted Mode of Epigenetic Control in the Developing and Adult Brain.

Authors:  Julio D Perez; Nimrod D Rubinstein; Catherine Dulac
Journal:  Annu Rev Neurosci       Date:  2016-04-25       Impact factor: 12.449

10.  Regulatory elements associated with paternally-expressed genes in the imprinted murine Angelman/Prader-Willi syndrome domain.

Authors:  Sara Rodriguez-Jato; Jixiu Shan; Jyoti Khadake; Arnold D Heggestad; Xiaojie Ma; Karen A Johnstone; James L Resnick; Thomas P Yang
Journal:  PLoS One       Date:  2013-02-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.